Qhslab, INC. (USAQ) — 10-Q Filings

All 10-Q filings from Qhslab, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

USAQ Revenue Jumps 32%, But Soaring Costs Drive Net Loss — Nov 13, 2025 Risk: high
QHSLab, Inc. (USAQ) reported a mixed financial performance for the nine months ended September 30, 2025. Revenue increased significantly to $1,987,931, up from
QHSLab Revenue Jumps 30%, But Losses Widen Amid Soaring Costs — Aug 14, 2025 Risk: high
QHSLab, Inc. reported a significant increase in revenue for the three and six months ended June 30, 2025. Revenue for the three-month period rose to $605,446 fr
QHSLab, Inc. Files Q1 2025 10-Q — May 14, 2025 Risk: low
QHSLab, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including balance shee
QHSLab, Inc. Files Q3 2024 10-Q — Nov 13, 2024 Risk: low
QHSLab, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is
QHSLab, Inc. Files 10-Q for Q2 2024 — Aug 14, 2024 Risk: low
QHSLab, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is inco
QHSLab, Inc. Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: low
QHSLab, Inc. (USAQ) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. QHSLab, Inc. filed a 10-Q report for the period ending March 31, 2024. The com

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX